Gemcitabine-induced radiation recall dermatitis: case report

Tumori. 2001 Nov-Dec;87(6):428-30. doi: 10.1177/030089160108700614.

Abstract

A 65-year-old male with lung adenocarcinoma received radiotherapy to the mediastinum and right upper lobe, followed by chemotherapy with gemcitabine. Radiation recall dermatitis developed in the area corresponding to the radiotherapy portal. This is one of just a few cases reported recently concerning radiation recall dermatitis stemming from gemcitabine.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / radiotherapy
  • Aged
  • Antimetabolites, Antineoplastic / adverse effects*
  • Chemotherapy, Adjuvant
  • Deoxycytidine / adverse effects*
  • Deoxycytidine / analogs & derivatives*
  • Gemcitabine
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / radiotherapy
  • Male
  • Mental Recall
  • Radiation-Sensitizing Agents / adverse effects*
  • Radiodermatitis / etiology*
  • Radiotherapy, Adjuvant
  • Skin / drug effects*
  • Skin / radiation effects*

Substances

  • Antimetabolites, Antineoplastic
  • Radiation-Sensitizing Agents
  • Deoxycytidine
  • Gemcitabine